| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.322 | 47.421 | - | - | - | - | - | - | - | - |
| Total Income - EUR | 26.322 | 47.421 | - | - | - | - | - | - | - | - |
| Total Expenses - EUR | 22.622 | 39.985 | - | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 3.699 | 7.436 | - | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 2.914 | 6.962 | - | - | - | - | - | - | - | - |
| Employees | 3 | 3 | - | - | - | - | - | - | - | - |
Check the financial reports for the company - Eval Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.566 | 4.865 | - | - | - | - | - | - | - | - |
| Current Assets | 2.023 | 5.964 | - | - | - | - | - | - | - | - |
| Inventories | 0 | 0 | - | - | - | - | - | - | - | - |
| Receivables | 0 | 0 | - | - | - | - | - | - | - | - |
| Cash | 2.023 | 5.964 | - | - | - | - | - | - | - | - |
| Shareholders Funds | 2.959 | 9.891 | - | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | - | - | - | - | - | - | - | - |
| Debts | 733 | 1.013 | - | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Eval Bio S.r.l.